• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Editorial
Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma
Valerie Chew
Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore 169856, Singapore
Correspondence :  Valerie Chew ,
Tel: +65-65767181, Fax: +65-62210975, Email: valerie.chew@duke-nus.edu.sg
Received: March 25, 2025   Accepted: March 28, 2025
KeyWords: CD36, CD8 T cell, NRF2, T cell exhaustion, tumour microenvironment, HCC
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 384 View
  • 31 Download
ORCID iDs

Valerie Chew
https://orcid.org/0000-0002-5617-0936

Related articles

Correspondence to editorial “Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma”

CD36 Promotes Iron Accumulation and Dysfunction in CD8+ T Cells via the p38-CEBPB-TfR1 Axis in Early-stage Hepatocellular Carcinoma

Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma2025 April;31(2)

Insights on risk score development: Considerations for early-stage hepatocellular carcinoma models2025 January;31(1)

Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma2025 January;31(1)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1461
TOTAL : 2693255
Close layer